Tuesday, August 19, 2025
No menu items!
HomeNatureImmunotherapy using CAR T cells shows promising long-term outcomes for people with...

Immunotherapy using CAR T cells shows promising long-term outcomes for people with the blood cancer myeloma

  • Jagannath, S. et al. J. Clin. Oncol. https://doi.org/10.1200/JCO-25-00760 (2025).

    Article 

    Google Scholar
     

  • Yong, K. et al. Br. J. Haematol. 175, 252–264 (2016).

    Article 
    PubMed 

    Google Scholar
     

  • Mateos M.-V. et al. Leukemia 38, 2554–2560 (2024).

    Article 
    PubMed 

    Google Scholar
     

  • Costa, L. J. et al. Blood 138, 3786–3788 (2021).

    Article 

    Google Scholar
     

  • Martin, T. et al. J. Clin. Oncol. 41, 1265–1274 (2023).

    Article 
    PubMed 

    Google Scholar
     

  • Garfall, A. L. et al. Clin. Lymphoma Myeloma Leuk. 24, S548 (2024).

    Article 

    Google Scholar
     

  • Tomasson, M. H. et al. Hemasphere 8, e136 (2024).

    Article 
    PubMed 

    Google Scholar
     

  • Swan, D., Madduri, D. & Hocking, J. Blood Cancer J. 14, 206 (2024).

    Article 
    PubMed 

    Google Scholar
     

  • Tix, T. et al. Clin. Cancer Res. 30, 4690–4700 (2024).

    Article 
    PubMed 

    Google Scholar
     

  • Freeman, C. L. et al. Blood 144, 1031–1033 (2024).

    Article 
    PubMed 

    Google Scholar
     

  • Fonseca, R. et al. BMC Cancer 20, 1087 (2020).

    Article 
    PubMed 

    Google Scholar
     

  • San-Miguel, J. et al. N. Engl. J. Med. 389, 335–347 (2023).

    Article 
    PubMed 

    Google Scholar
     

  • RELATED ARTICLES

    Most Popular

    Recent Comments